| Consolidated Statements of      Financial Position  |    | As of      October 31, 2007  |
|----------------------------------------------------------|--------------|-----------------------------------|
|                                      |    | Previously Reported     |    | Adjustments  | Restated  |
| Property, plant and equipment, net                  | $       | 386                          | $  | 589  | a  | $                975  |
| Intangible assets, net                              |    | 583                          |    | (364)  | b  | 219  |
| MAPLE financial liability                           |    | -                            |    | 161  | c  | 161  |
| Deferred tax liabilities                            |    | 168                          |    | 20  | d  | 188  |
| Retained earnings                                   |    | 842                          |    | 38  | e  | 880  |
| Accumulated other comprehensive      income         |    | 490                          |    | 6  |    | 496  |
| Consolidated Statements of      Operations        |    | For the year      ended October 31, 2007  |
|--------------------------------------------------------|--------------|------------------------------------------------|
|                                    |    | PreviouslyReported                        |    | Adjustments  | Restated  |
| Interest expense                                  | $       | (27)                                      | $  | 12  | e  | $                (15)  |
| Income tax (expense) – deferred             |    | (2)                                       |    | (4)  | e  | (6)  |
| Net (loss) income                                 | $       | 773                                       | $  | 8  |    | $                 781  |
| Basic (loss) earnings per share                   |    |                                      |    |    |    |    |
|    - from continuing      operations    |    | (0.25)                                    |    | 0.06  |    | (0.19)  |
|    - from discontinued      operations  |    | 6.12                                      |    | -  |    | 6.12  |
|                                              | $       | 5.87                                      | $  | 0.06  |    | $5.93  |
| Diluted (loss) earnings per share                 |    |                                      |    |    |    |    |
|    - from continuing      operations    |    | (0.25)                                    |    | 0.06  |    | (0.19)  |
|    - from discontinued      operations  |    | 6.11                                      |    | -  |    | 6.11  |
|                                              | $       | 5.86                                      | $  | 0.06  |    | $          5.92  |
| Consolidated Statements of      Operations        |    | For the year      ended October 31, 2006  |
|--------------------------------------------------------|--------------|------------------------------------------------|
|                                    |    | Previously Reported                  |    | Adjustments  | Restated  |
|                                              |    |                                      |    |    |    |    |
| Other income (expenses) - net                     | $       | (36)                                      | $  | 36  | e  | $                    -  |
| Interest expense                                  |    | (21)                                      |    | 7  | e  | (14)  |
| Income tax (expense) - deferred                   |    | (30)                                      |    | (13)  | e  | (43)  |
| Net (loss) income                                 | $       | 120                                       | $  | 30  |    | $                150  |
|                                              |    |                                      |    |    |    |    |
| Basic (loss) earnings per share                   |    |                                      |    |    |    |    |
|    - from continuing      operations    |    | 0.15                                      |    | 0.21  |    | 0.36  |
|    - from discontinued      operations  |    | 0.68                                      |    | -  |    | 0.68  |
|                                              | $       | 0.83                                      | $  | 0.21  |    | $               1.04  |
|                                              |    |                                      |    |    |    |    |
| Diluted (loss) earnings per share                 |    |                                      |    |    |    |    |
|    - from continuing      operations    |    | 0.15                                      |    | 0.21  |    | 0.36  |
|    - from discontinued      operations  |    | 0.68                                      |    | -  |    | 0.68  |
|                                              | $       | 0.83                                      | $  | 0.21  |    | $               1.04  |
|     (a)  | Recording of      construction in-progress and capitalized interest related to lease      accounting                                                                                         | $       | 589    |
|-----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------------|
|                         | Additional      construction in-progress and capitalized interest during fiscal 2008                                                                                                         |    | 39     |
|                         | Impact of      foreign currency translation as at October 31, 2008                                                                                                                           |    | (127)  |
|                         | Construction      in-progress and capitalized interest related to lease accounting as at      October 31, 2008                                                                               | $       | 501    |
| (b)                          | Reversal of      intangible assets for long-term supply agreement recognized in fiscal      2006                                                                                             | $       | (364)  |
|     (c)  | Recording of      MAPLE financial liability                                                                                                                                                  | $       | 161    |
|                         | Additional MAPLE      financial liability during fiscal 2008                                                                                                                                 |    | 34     |
|                         | Impact of      foreign currency translation as of October 31, 2008                                                                                                                           |    | (35)   |
|                         | MAPLE financial      liability as of October 31, 2008                                                                                                                                        | $       | 160    |
| (d)                          | Deferred tax      liabilities relating to capitalized interest and reversal of loss on      non-monetary transaction                                                                         | $       | 20     |
| (e)                          | Fiscal 2007      consolidated statement of operations adjustments for capitalized interest      and taxes                                                                                    | $       | 8      |
|                         | Fiscal 2006      consolidated statement of operations adjustments for reversal of loss on      non-monetary            transaction, capitalized interest and taxes  |    | 30     |
|                         | Total impact on      retained earnings as of October 31, 2007                                                                                                                                | $       | 38     |
|                                                                          |    |    |    | Restated     |    | Restated      |
|------------------------------------------------------------------------------------|--------------|--------------|--------------|-------------------|--------------|--------------------|
|                                                                          |    | 2008    |    | 2007         |    | 2006          |
| Total revenues                                                                | $       | 1,315   | $       |  1,210  |    | $      1,060  |
| Reimbursement revenues                                                        |    | (100)   |    | (91)         |    | (105)         |
| Net revenues                                                                  | $       | 1,215   | $       | 1,119        | $       |  955     |
| (Loss) income from continuing      operations                                 | $       | (553)   | $       |  (25)   | $       |  52      |
| Income taxes                                                                  |    | (91)    |    | (19)         |    | (22)          |
| Net interest expense (income)                                                 |    | 2       |    | (10)         |    | (1)           |
| Change in fair value of interest rate      swaps                              |    | (2)     |    | (1)          |    | -             |
| Depreciation and amortization                                                 |    | 100     |    | 79           |    | 51            |
| EBITDA                                                                        |    | (544)   |    | 24           |    | 80            |
| Restructuring charges - net                                                   |    | 15      |    | 37           |    | (7)           |
| Other impairment of long-lived      assets                                    |    | 11      |    | -            |    | -             |
| Valuation provisions and investment      write-downs                          |    | 11      |    | 8            |    | 6             |
| Loss (gain) on sale of a      business/investment and other long-term assets  |    | 3       |    | (4)          |    | (2)           |
| FDA provision                                                                 |    | (10)    |    | 61           |    | -             |
| Acquisition integration                                                       |    | 4       |    | 19           |    | -             |
| Impairment of goodwill                                                        |    | 320     |    | -            |    | -             |
| MAPLE Facilities leasereassessment:                                           |    |    |    |         |    |          |
|    Write-off of      construction-in-progress                       |    | 501     |    |         |    |          |
|    Write-off of financial      liability                            |    | (160)   |    | -            |    | -             |
| Adjusted EBITDA                                                               | $       | 151     | $       |  145    | $       |  77      |
| Adjusted EBITDA      margin                                                   |    | 12%     |    | 13%          |    | 8%            |
|                                                     |    | 2008               |    |  % of net      revenues  |    | Restated      2007  | % of net      revenues  |    | Restated      2006  | % of net      revenues  |
|---------------------------------------------------------------|--------------|-------------------------|--------------|------------------------------------|--------------|--------------------------|------------------------------|--------------|--------------------------|------------------------------|
| Product revenues                                         | $       | 636                | $       | 52%                           | $       |  564           | 50%                     | $       |  438           | 46%                     |
| Service revenues                                         |    | 579                |    | 48%                           |    | 555                 | 50%                     |    | 517                 | 54%                     |
| Net revenues                                             |    | 1,215              |    | 100%                          |    | 1,119               | 100%                    |    | 955                 | 100%                    |
| Reimbursement revenues                                   |    | 100                |    |                          |    | 91                  |                    |    | 105                 |                    |
| Total revenues                                           |    | 1,315              |    |                          |    | 1,210               |                    |    | 1,060               |                    |
| Direct cost of products                                  |    | (387)              |    | (32%)                         |    | (360)               | (32%)                   |    | (296)               | (31%)                   |
| Direct cost of services                                  |    | (374)              |    | (31%)                         |    | (338)               | (30%)                   |    | (362)               | (38%)                   |
| Reimbursed expenses                                      |    | (100)              |    |                          |    | (91)                |                    |    | (105)               |                    |
| Selling, general and  administration           |    | (280)              |    | (23%)                         |    | (265)               | (24%)                   |    | (220)               | (23%)                   |
| Research and development                                 |    | (79)               |    | (7%)                          |    | (68)                | (6%)                    |    | (53)                | (6%)                    |
| Depreciation and amortization                            |    | (100)              |    | (8%)                          |    | (79)                | (7%)                    |    | (51)                | (5%)                    |
| MAPLE Facilities lease      reassessment:                |    |               |    |                          |    |                |                    |    |                |                    |
| Write-off of construction-in- progress              |    |   (501)  |    |   (41%)             |    |   -       |   -           |    |   -       |   -           |
| Write-off of financialliability                          |    | 160                |    | 13%                           |    | -                   | -                       |    | -                   | -                       |
| Other impairment of long-lived  assets         |    | (11)               |    | (1%)                          |    | -                   | -                       |    | -                   | -                       |
| Impairment of goodwill                                   |    | (320)              |    | (26%)                         |    | -                   | -                       |    | -                   | -                       |
| Restructuring charges - net                              |    | (13)               |    | (1%)                          |    | (37)                | (3%)                    |    | 7                   | 1%                      |
| Change in fair value of  embedded derivatives  |    | (14)               |    | (1%)                          |    | 4                   | -                       |    | -                   | -                       |
| Other income (expenses) - net                            |    | 11                 |    | 1%                            |    | (84)                | (8%)                    |    | -                   | -                       |
| Operating loss from continuing      operations           | $       | (693)              | $       | (57%)                         | $       | (108)               | (10%)                   | $       | (20)                | (2%)                    |
| Margins:                                                 |    |               |    |                          |    |                |                    |    |                |                    |
| Gross margin on products                                 |    | 39%                |    |                          |    | 36%                 |                    |    | 32%                 |                    |
| Gross margin on services                                 |    | 35%                |    |                          |    | 39%                 |                    |    | 30%                 |                    |
| Capital      expenditures                                | $       | 52                 |    |                          | $       | 71                  |                    | $       | 51                  |                    |
|                                                                                             |    | 2008    |    | Restated2007  |    | Restated2006  |
|-------------------------------------------------------------------------------------------------------|--------------|--------------|--------------|--------------------|--------------|--------------------|
| Basic      (loss) earnings per share from continuing operations –  as reported        | $       | (4.54)  | $       | (0.19)        | $       | 0.36          |
| Adjusted for:                                                                                    |    |    |    |          |    |          |
| Restructuring charges - net                                                                      |    | 0.08    |    | 0.19          |    | (0.04)        |
| FDA provision                                                                                    |    | (0.06)  |    | 0.31          |    | -             |
| Other impairment of long-lived      assets                                                       |    | 0.07    |    | -             |    | -             |
| Valuation provisions and      investment write-downs                                             |    | 0.09    |    | 0.06          |    | 0.05          |
| Change in fair value of interest      rate swaps                                                 |    | (0.02)  |    | (0.01)        |    | -             |
| Loss (gain) on sale of      business/investments and other long-term assets                      |    | 0.01    |    | (0.02)        |    | -             |
| Acquisition integration                                                                          |    | 0.02    |    | 0.09          |    | -             |
| Impairment of goodwill                                                                           |    | 2.63    |    | -             |    | -             |
| Write-off related to the MAPLE      Facilities lease reassessment                                |    | 2.02    |    | -             |    | -             |
| Tax rate changes                                                                                 |    | (0.09)  |    | -             |    | (0.03)        |
| Adjusted EPS                                                                                     | $       | 0.21    | $       | 0.43          | $       | 0.34          |
| (millions of US dollars)                                                     |    | 2008    |    | Restated2007  |    | Restated      2006  |
|-----------------------------------------------------------------------------------|--------------|--------------|--------------|--------------------|--------------|--------------------------|
| (Loss)      income from continuing operations – as reported            | $       | (553)   | $       | (25)          | $       | 52                  |
| Adjusted for (after tax):                                                    |    |    |    |          |    |                |
| Restructuring charges – net                                            |    | 10      |    | 25            |    | (6)                 |
| FDA provision                                                                |    | (7)     |    | 41            |    | -                   |
| Other impairment of long-lived      assets                                   |    | 8       |    | -             |    | -                   |
| Valuation provisions and      investment write-downs                         |    | 11      |    | 8             |    | 7                   |
| Change in fair value of interest      rate swaps                             |    | (2)     |    | (1)           |    | -                   |
| Loss (gain) on sale of      business/investments and other long-term assets  |    | 1       |    | (3)           |    | -                   |
| Acquisition integration                                                      |    | 3       |    | 12            |    | -                   |
| Impairment of goodwill                                                       |    | 320     |    | -             |    | -                   |
| Write-off related to the MAPLE      Facilities lease reassessment            |    | 246     |    | -             |    | -                   |
| Tax rate changes                                                             |    | (11)    |    | -             |    | (4)                 |
| Adjusted income from      continuing operations                              | $       | 26      | $       | 57            | $       | 49                  |
|                                                                                                                   | 2008                                      |  % of net      revenues  | Restated2007     | % of net      revenues  | Restated2006     | % of net      revenues  |
|-----------------------------------------------------------------------------------------------------------------------------|------------------------------------------------|------------------------------------|-----------------------|------------------------------|-----------------------|------------------------------|
| Early stage                                                                                                            |          $       264  | 55%                           | $254             | 53%                     | $267             | 58%                     |
| Late stage                                                                                                             | 218                                       | 45%                           | 223              | 47%                     | 191              | 42%                     |
| Net revenues                                                                                                           | 482                                       | 100%                          | 477              | 100%                    | 458              | 100%                    |
| Reimbursement revenues                                                                                                 | 100                                       |                          | 91               |                    | 105              |                    |
| Total revenues                                                                                                         | 582                                       |                          | 568              |                    | 563              |                    |
| Cost of      revenues                       | (356)                                     | (74%)                         | (332)            | (70%)                   | (359)            | (78%)                   |
| Reimbursed expenses                                                                                                    | (100)                                     |                          | (91)             |                    | (105)            |                    |
| Selling, general and      administration                                                                               | (127)                                     | (26%)                         | (130)            | (27%)                   | (125)            | (27%)                   |
| Research and development                                                                                               | -                                         | -                             | -                | -                       | -                | -                       |
| Depreciation and amortization                                                                                          | (35)                                      | (7%)                          | (35)             | (7%)                    | (30)             | (7%)                    |
| Other impairment of long-lived      assets                                                                             | (11)                                      | (2%)                          | -                | -                       | -                | -                       |
| Impairment of goodwill                                                                                                 | (320)                                     | (66%)                         | -                | -                       | -                | -                       |
| Restructuring charges – net                                                                                      | (9)                                       | (2%)                          | (28)             | (6%)                    | -                | -                       |
| Change in fair value of embedded      derivatives                                                                      | 1                                         | -                             | -                | -                       | -                | -                       |
| Other income (expenses) - net                                                                                          | 22                                        | 5%                            | (74)             | (16%)                   | 2                | -                       |
| Operating (loss) income                                                                                                | (353)                                     | (73%)                         | (122)            | (26%)                   | (54)             | (12%)                   |
| Adjustments:                                                                                                           |                                      |                          |             |                    |             |                    |
| Impairment of goodwill                                                                                                 | 320                                       | 66%                           | -                | -                       | -                | -                       |
| FDA provision                                                                                                          | (10)                                      | (2%)                          | 61               | 13%                     | -                | -                       |
| Restructuring charges - net                                                                                            | 9                                         | 2%                            | 28               | 6%                      | -                | -                       |
| Other impairment of long-lived      assets                                                                             | 11                                        | 2%                            | -                | -                       | -                | -                       |
| Loss (gain) on sale of business                                                                                        | (1)                                       | -                             | 4                | 1%                      | (2)              | -                       |
|                                                                                                                   | (24)                                      | (5%)                          | (29)             | (6%)                    | (56)             | (12%)                   |
| Depreciation and amortization                                                                                          | 35                                        | 7%                            | 35               | 7%                      | 30               | 7%                      |
| Adjusted EBITDA                                                                                                        | $         11               | 2%                            | $   6  | 1%                      | ($      26)      | (6%)                    |
| Margins:                                                                                                               |                                      |                          |             |                    |             |                    |
| Gross margin                                                                                                           | 26%                                       |                          | 30%              |                    | 22%              |                    |
| Adjusted EBITDA                                                                                                        | 2%                                        |                          | 1%               |                    | (6%)             |                    |
| Capital      expenditures                                                                                              | $   29                          |                          | $ 48             |                    | $       37  |                    |
| Orders                              | New Orders         | Previously Reported Period-End Backlog  | Adjustments       | Period-End Backlog  |
|------------------------------------------|-------------------------|----------------------------------------------|------------------------|--------------------------|
| Fiscal      2007 – Quarter 1  | $   159  | $   472                       | $   24  | $   496   |
| Quarter      2                      | 103                | 428                                     | 35                | 463                 |
| Quarter      3                      | 119                | 408                                     | 37                | 445                 |
| Quarter      4                      | 134                | 375                                     | 51                | 426                 |
| Fiscal      2008 – Quarter 1  | 177                | 395                                     | 53                | 448                 |
| Quarter      2 Quarter      3  | 165169             | 431486                                  | 65 65        | 496551              |
| Quarter 4                           | 131                |                                    |              | 485                 |
|                                                              | 2008                                    | % of net revenues  | Restated2007                       | % of net      revenues  | Restated2006                       | % of net      revenues  |
|------------------------------------------------------------------------|----------------------------------------------|-------------------------|-----------------------------------------|------------------------------|-----------------------------------------|------------------------------|
| Product revenues                                                  | $   290                       | 98%                | $   284                  | 98%                     |  $  290                  | 98%                     |
| Service revenues                                                  | 6                                       | 2%                 | 6                                  | 2%                      | 5                                  | 2%                      |
| Net revenues                                                      | 296                                     | 100%               | 290                                | 100%                    | 295                                | 100%                    |
| Direct cost of      product         | (150)                                   | (51%)              | (147)                              | (51%)                   | (147)                              | (50%)                   |
| Direct cost of service                                            | (3)                                     | (1%)               | (3)                                | (1%)                    | (3)                                | (1%)                    |
| Selling, general and      administration                          | (48)                                    | (16%)              | (54)                               | (19%)                   | (51)                               | (17%)                   |
| Research and development                                          | (3)                                     | (1%)               | (4)                                | (1%)                    | (5)                                | (2%)                    |
| Depreciation and amortization                                     | (13)                                    | (4%)               | (13)                               | (4%)                    | (15)                               | (5%)                    |
| Restructuring charges – net                                 | -                                       |               | -                                  | -                       | 2                                  | 1%                      |
| Change in fair value ofembedded  derivatives            | (15)                                    | (5%)               | 4                                  | 1%                      | -                                  | -                       |
| MAPLE Facilities lease      reassessment:                         |                                    |               |                               |                    |                               |                    |
|   Write-off of      construction-in-progress                 | (501)                                   | (169%)             | -                                  | -                       | -                                  | -                       |
|   Write-off of financial      liability                      | 160                                     | 54%                | -                                  | -                       | -                                  | -                       |
| Other income (expenses) – net                               | (2)                                     | (1%)               | (1)                                | -                       | -                                  | -                       |
| Operating (loss)      income                                      | (279)                                   | (94)%              |      72        | 25%                     |    76                    | 26%                     |
| Adjustments:                                                      |                                    |               |                               |                    |                               |                    |
| MAPLE Facilities lease      reassessment:                         |                                    |               |                               |                    |                               |                    |
|   Write-off of      construction-in-progress                 | 501                                     | 169%               | -                                  | -                       | -                                  | -                       |
|   Write-off of financial      liability                      | (160)                                   | (54%)              | -                                  | -                       | -                                  | -                       |
| Loss (gain) on sale of a      business                            | 4                                       | 1%                 | (1)                                | -                       | -                                  | -                       |
| Restructuring charges – net                                 | -                                       | -                  | -                                  | -                       | (2)                                | (1%)                    |
|                                                              | 66                                      | 22%                |  71                           | 24%                     | 74                                 | 25%                     |
| Depreciation and amortization                                     | 13                                      | 4%                 | 13                                 | 4%                      | 15                                 | 5%                      |
| Adjusted EBITDA                                                   | $         79             | 27%                | $     84       | 29%                     | $   89                   | 30%                     |
| Margins:                                                          |                                    |               |                               |                    |                               |                    |
| Gross margin                                                      | 48%                                     |               |  48%                          |                    | 49%                                |                    |
| Adjusted EBITDA margin                                            | 27%                                     |               | 29%                                |                    | 30%                                |                    |
| Capital      expenditures                                         | $           8  |               | $      8  |                    | $      -  |                    |
|                                                        |    | 2008    | % of net revenues  |    | Restated2007  | % of net      revenues  |    | Restated2006  | % of net      revenues  |
|------------------------------------------------------------------|--------------|--------------|-------------------------|--------------|--------------------|------------------------------|--------------|--------------------|------------------------------|
| Product revenues                                            | $       | 346     | 79%                | $       | 280           | 80%                     | $       |  148     | 73%                     |
| Service revenues                                            |    | 91      | 21%                |    | 72            | 20%                     |    | 54            | 27%                     |
| Net revenues                                                |    | 437     | 100%               |    | 352           | 100%                    |    | 202           | 100%                    |
| Direct cost of products                                     |    | (237)   | (54%)              |    | (213)         | (61%)                   |    | (149)         | (74%)                   |
| Direct cost of services                                     |    | (15)    | (3%)               |    | (3)           | (1%)                    |    | -             | -                       |
| Selling, general and      administration                    |    | (80)    | (18%)              |    | (57)          | (16%)                   |    | (20)          | (10%)                   |
| Research and development                                    |    | (76)    | (17%)              |    | (64)          | (18%)                   |    | (48)          | (24%)                   |
| Depreciation and amortization                               |    | (51)    | (12%)              |    | (29)          | (8%)                    |    | (6)           | (3%)                    |
| Restructuring charges – net                           |    | (3)     | (1%)               |    | -             | -                       |    | -             | -                       |
| Other income (expenses) - net                               |    | (2)     | -                  |    | (6)           | (2%)                    |    | 5             | 2%                      |
| Operating (loss)      income                                |    | (27)    | (6%)               |    | (20)          | (6%)                    |    | (16)          | (8%)                    |
| Adjustments:                                                |    |    |               |    |          |                    |    |          |                    |
| Equity earnings                                             |    | 49      | 11%                |    | 53            | 15%                     |    | 54            | 27%                     |
| Valuation provisions and  investment write-downs  |    | 1       | -                  |    | -             | -                       |    | -             | -                       |
| Acquisition integration                                     |    | 4       | 1%                 |    | 19            | 5%                      |    | -             | -                       |
| Restructuring charges - net                                 |    | 5       | 1%                 |    | -             | -                       |    | -             | -                       |
|                                                        |    | 32      | 7%                 |    | 52            | 15%                     |    | 38            | 19%                     |
| Depreciation and amortization                               |    | 51      | 12%                |    | 29            | 8%                      |    | 6             | 3%                      |
| Adjusted EBITDA                                             | $       | 83      | 19%                | $       |  81      | 23%                     | $       |  44      | 22%                     |
| Margins:                                                    |    |    |               |    |          |                    |    |          |                    |
| Gross margin                                                |    | 42%     |               |    | 39%           |                    |    | 26%           |                    |
| Adjusted EBITDA margin                                      |    | 19%     |               |    | 23%           |                    |    | 22%           |                    |
| Capital      expenditures                                   | $       | 10      |               | $       |  8       |                    | $       | 4             |                    |
|                                                  |    | 2008    |    | Restated2007  |     | Restated2006  |
|------------------------------------------------------------|--------------|--------------|--------------|--------------------|---------------|--------------------|
| Selling, general and      administration              | $       | (25)    | $       |  (24)    | $        | (24)          |
| Depreciation and amortization                         |    | (1)     |    | (2)           |     | -             |
| Restructuring charges – net                     |    | (1)     |    | (9)           |     | 5             |
| Other income (expenses) – net                   |    | (7)     |    | (3)           |     | (7)           |
| Operating income      (loss)                          |    | (34)    |    | (38)          |     | (26)          |
| Adjustments:                                          |    |    |    |          |     |          |
| Equity earnings                                       |    | -       |    | -             |     | (4)           |
| Gain on sale of investments                           |    | -       |    | (7)           |     | -             |
| Valuation provisions and investment      write-downs  |    | 10      |    | 8             |     | 6             |
| Restructuring charges – net                     |    | 1       |    | 9             |     | (5)           |
| Depreciation and amortization                         |    | 1       |    | 2             |     | -             |
| Adjusted EBITDA                                       | $       | (22)    | $       | (26)          |  $  | (29)          |
|                                                                                     |    | 2008    |    | 2007   |    | 2006   |
|-----------------------------------------------------------------------------------------------|--------------|--------------|--------------|-------------|--------------|-------------|
| Net revenues                                                                             | $       | -       | $       | 95     | $       | 362    |
| Cost of revenues                                                                         |    | -       |    | (57)   |    | (225)  |
| Selling, general and      administration                                                 |    | -       |    | (16)   |    | (53)   |
| Depreciation and amortization                                                            |    | -       |    | -      |    | (10)   |
| Restructuring charges - net                                                              |    | -       |    | -      |    | (1)    |
| Other income (expenses) - net                                                            |    | -       |    | -      |    | (3)    |
| Operating income                                                                         |    |    |    | 22     |    | 70     |
| Gain on sale of discontinued      operations          |    | -       |    | 904    |    | 24     |
| Dividend and interest income                                                             |    | -       |    | 1      |    | 2      |
| Income taxes                                                                             |    | -       |    | (117)  |    | 7      |
| Minority interest                                                                        |    | -       |    | (5)    |    | (8)    |
| Equity earnings                                                                          |    | -       |    | 1      |    | 3      |
| Income from discontinued      operations – net of income taxes                     | $       | -       | $       | 806    | $       | 98     |
| Basic EPS from discontinued      operations                                              | $       | -       | $       | 6.12   | $       | 0.68   |
|                                                                         |    | 2008   |    | Restated2007  | Change  |
|-----------------------------------------------------------------------------------|--------------|-------------|--------------|--------------------|--------------|
| Cash and cash equivalents, restricted      cash, and short-term investments  | $       | 133    | $       | 337           | (61%)   |
| Operating working capital1                                                   | $       | 89     | $       | 59            | 51%     |
| Cash (used in) provided by continuing      operating activities              | $       | (18)   | $       | 176           | (110%)  |
| Cash provided by (used in) continuing      investing activities              | $       | 60     | $       | (627)         | 110%    |
| Cash (used in) provided by continuing      financing activities              | $       | (126)  | $       | (447)         | 72%     |
| Current ratio (excludes net assets held      for sale)                       |    | 2.0    |    | 1.6           | 25%     |
|                                                            | 2009    | 2010  | 2011    | 2012  | 2013    | Thereafter  |
|----------------------------------------------------------------------|--------------|------------|--------------|------------|--------------|------------------|
| Long-term debt                                                  | $       | 17    | $       | 27    | $       | 14          | $  | 14  | $  | 171  | $  | 31  |
| Capital leases                                                  |    | 2     |    | 1     |    | 2           |    | 3  |    | -  |    | -  |
| Interest on long-term      debt   and capital leases  |    | 15    |    | 13    |    | 12          |    | 11  |    | 6  |    | -  |
| Operating leases                                                |    | 30    |    | 28    |    | 23          |    | 18  |    | 13  |    | 23  |
| Purchase obligations                                            |    | 22    |    | 21    |    | 24          |    | 28  |    | 18  |    | 166  |
| Other contractual         commitments                 |    | 34    |    | 20    |    | 15          |    | 5  |    | 1  |    | -  |
|                                                            | $       | 120   | $       | 110   | $       | 90          | $  | 79  | $  | 209  | $  | 220  |
|                                                                               |    | 2008   |    | Restated2007  |    | Change  |
|-----------------------------------------------------------------------------------------|--------------|-------------|--------------|--------------------|--------------|--------------|
| Long-term debt                                                                     | $       | 282    | $       | 384           |    | (27%)   |
| Less: cash and cash equivalents,      restricted cash, and short-term investments  |    | (133)  |    | (337)         |    | (61%)   |
| Net debt                                                                           |    | 149    |    | 47            |    | 217%    |
| Shareholders’ equity                                                         |    | 1,090  |    | 1,941         |    | (44)%   |
| Capital employed1                                                                  | $       | 1,239  | $       | 1,988         |    | (38)%   |
| Shares issued and outstanding          |    | 2008     |    | 2007      |    | 2006     |
|---------------------------------------------|--------------|---------------|--------------|----------------|--------------|---------------|
| Outstanding beginning of the year      |    | 122,578  |    | 144,319   |    | 142,099  |
| Issued during the year                 |    | 462      |    | 1,090     |    | 2,220    |
| Repurchased and cancelled              |    | (2,903)  |    | (22,831)  |    | -        |
| Outstanding  – end of year  |    | 120,137  |    | 122,578   |    | 144,319  |
| Dividends declared per share           | $       | -        | $       | 0.03      | $       | 0.13     |
| Market price per share:                |    |     |    |      |    |     |
|      High          | $       | 22.55    | $       | 22.49     | $       | 20.60    |
|      Average       | $       | 16.67    | $       | 19.27     | $       | 18.36    |
|      Low           | $       | 8.54     | $       | 16.91     | $       | 15.66    |
| Book value per share1                  | $       | 9.07     | $       | 15.83     | $       | 9.59     |
| (millions of US dollars, except earnings per share)       |                |                 |               |               |                      |         |   |   |
|-----------------------------------------------------------|---------------------|----------------------|--------------------|--------------------|---------------------------|--------------|--------|--------|
|                                                      | Fiscal 2008         | October 2008         | Restated July 2008 | RestatedApril 2008 | RestatedJanuary 2008      |
| Net revenues                                              | $                   | 1,215                |               | 295                | $                         | 298          | $      | 326    | $ | 296 |
| Operating (loss) income                                   |                | (693)                |               | (673)              |                      | (22)         |   | 8      |   | (6) |
|                                                      |                |                 |               |               |                      |         |   |   |   |   |
| (Loss) income from continuing operations                  |                | (553)           |               | (575)              |                      | (10)         |   | 13     |   | 19 |
| Net (loss) income                                         |                | (553)                |               | (575)              |                      | (10)         |   | 13     |   | 19 |
| (Loss) earnings per share from      continuing operations |                |                 |               |               |                      |         |   |   |   |   |
| Basic                                                     |                | (4.54)               |               | (4.77)             |                      | (0.08)       |   | 0.11   |   | 0.16 |
| Diluted                                                   |                | (4.54)               |               | (4.77)             |                      | (0.08)       |   | 0.11   |   | 0.15 |
| (Loss) earnings per    share                              |                |                 |               |               |                      |         |   |   |   |   |
| Basic                                                     |                | (4.54)               |               | (4.77)             |                      | (0.08)       |   | 0.11   |   | 0.16 |
| Diluted                                                   |                | (4.54)               |               | (4.77)             |                      | (0.08)       |   | 0.11   |   | 0.16 |
|  (millions of US dollars, except earnings per share) |                |                 |               |               |                      |         |   |   |    |
|                                                      | RestatedFiscal 2007 | RestatedOctober 2007 | RestatedJuly 2007  | RestatedApril 2007 | RestatedJanuary 2007 |    |
| Net revenues                                              | $                   | 1,119                | $                  | 307                | $                         | 308          | $      | 263    | $ | 241 |    |
| Operating (loss) income                                   |                | (108)                |               | 1                  |                      | (4)          |   | (96)   |   | (9) |    |
|                                                      |                |                 |               |               |                      |         |   |   |   |   |    |
| (Loss) income from continuing operations                  |                | (25)            |               | 17                 |                      | 9            |   | (53)   |   | 2 |    |
| Net income                                                |                | 781                  |               | 15                 |                      | 9            |   | 739    |   | 18 |    |
| (Loss) earnings per share from      continuing operations |                |                 |               |               |                      |         |   |   |   |   |    |
| Basic                                                     |                | (0.19)               |               | 0.14               |                      | 0.07         |   | (0.39) |   | 0.01 |    |
| Diluted                                                   |                | (0.19)               |               | 0.14               |                      | 0.07         |   | (0.38) |   | 0.01 |    |
| Earnings per share                                        |                |                 |               |               |                      |         |   |   |   |   |    |
| Basic                                                     |                | 5.93                 |               | 0.13               |                      | 0.07         |   | 5.38   |   | 0.12 |    |
| Diluted                                                   |                | 5.92                 |               | 0.13               |                      | 0.07         |   | 5.37   |   | 0.12 |    |
|                                     | 2007 Restated Results  | September 2008 Guidance  | 2008      Actual Results  |
|-----------------------------------------------|-----------------------------|-------------------------------|--------------------------------|
| Total revenues                                | $                      | 1,210                    | $                         | 1,330 –  1,350  | $  | 1,315  |
| Net      revenue                              |  $                | 1,119                    | $                         | 1,230 –  1,250  | $  | 1,215  |
| Adjusted      EBITDA                          | $                      | 145                      | $                         | 160 – 170  | $  | 151  |
| Adjusted      EPS                             | $                      | 0.43                     | $                         | 0.27 –  0.33  | $  | 0.21  |
| Income (loss) from      continuing operations | $                      | (25)                     | $                         | 18 – 28  | $  | (553)  |
| Basic      EPS                                | $                      | (0.19)                   | $                         | 0.15 –  0.23  | $  | (4.54)  |
| Capital      expenditures                     | $                      | 71                       | $                         | 50 –  60  | $  | 52  |
| Effective tax      rate                       |                   | 43%                      |                      | 10% –      20%  |    | 14%  |
|                                               |                             |                               |                                |  |  |  |  |